Pediatric OTC and Supplement Poisonings


“Pediatric OTC and Supplement Poisonings”

Wednesday, May 28th, 2025 | 12:00 – 01:00 PM Eastern | Zoom

Speaker

[empty]

Oliver Grundmann, BPharm, MS, PhD

Department of Medicinal Chemistry

University of Florida College of Pharmacy


Program Details

  • Intended Audience:  Pharmacists
  • Universal Activity Number: 0012-0000-25-020-L01-P
  • Contact Hours: 1.0 hour of ACPE continuing education for pharmacists
  • Program Fees: 
    • Regular Registration: $10.00
    • UF Preceptor/Career Coach: $5.00
    • UF COP Faculty: $0.00 (Free!)
  • UAN Release Date: 05/28/2025
  • UAN Expiration Date: 12/31/2025
  • Activity Type: Knowledge
  • Program Support: No outside financial support was provided.
  • Format Type: Live, webinar (Zoom)
  • Time to Complete: Course completion requirements must be met within 15 days following the conclusion of the webinar.

Summary

Pediatric exposures to OTC medications and dietary/herbal supplements are primarily accidental but not insignificant with more than half of exposures below the age of 20 and 40% below the age of 6. Among the most frequently encountered substances in pediatric poisonings are analgesics, dietary supplements, antihistamines, and vitamins. Although a majority of exposures led to no or minimal toxicity that did not require follow-up, pediatric patients remain a primary population of concern due to the differences in pharmacokinetic and pharmacodynamic processes from adults.

This course is approved by the Florida Board of Pharmacy for 1.0 live general hours to meet pharmacist renewal requirements outlined in Rule 64B16-26.103.


Objectives

At the completion of this activity, the participant will be able to:

  1. Recall the most common substance exposures in pediatric patients.
  2. Determine the risk of adverse effects and toxicity in a pediatric patient based on potential substances.
  3. Develop a treatment plan for the top pediatric substance exposures.

Requirements for Successful Course Completion

In order to earn credit for this course, participants must attend the webinar live. Additionally, within 15 days of attending the webinar, participants must complete a course evaluation form.


Continuing Pharmacy Education Requirements

Pharmacy continuing education credit will be earned based on completion of this activity. To receive continuing education credit, your completion must be verified, and a program evaluation must be completed and submitted at the end of the program. Credit will be issued through the CPE Monitor and CE Broker websites.

Florida consultant pharmacist (or Florida pharmacist) numbers, NABP e-Profile ID numbers and participant’s Month and Day of Birth are required for credit issuance. UF CPE is not responsible for unissued education credits where the required information is either omitted or submitted incorrectly. UF CPE will contact registrants once by email to attempt to obtain missing or invalid information.


Course Access

The Zoom link will be provided in your receipt of payment. For additional assistance, please see our contact information below.


Disclosure Statement

Oliver Grundmann, BPharm, MS, PhD (Planning Committee, Faculty) has disclosed that he is performing an expert report on the toxicity of kratom for Kava Co, LLC. All relevant financial relationships for Dr. Grundmann have been mitigated. No other faculty, planners, or others in a position to control content have any financial relationships with ineligible companies to disclose.

Visit https://cpe.pharmacy.ufl.edu/coi-resources/ for more information on management of conflicts of interest.


Additional Resources

Please review the resources below before registering for the course.


ACPE logo

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.